Mizuho Securities Maintains Teleflex(TFX.US) With Hold Rating, Cuts Target Price to $230
Teleflex Analyst Ratings
Needham Maintains Teleflex(TFX.US) With Hold Rating
Needham Reaffirms Their Hold Rating on Teleflex (TFX)
C.L. King Maintains Teleflex(TFX.US) With Buy Rating, Cuts Target Price to $274
Teleflex Analyst Ratings
Truist Financial Maintains Teleflex(TFX.US) With Hold Rating, Maintains Target Price $227
A Quick Look at Today's Ratings for Teleflex(TFX.US), With a Forecast Between $227 to $285
Teleflex Is Maintained at Outperform by RBC Capital
Jefferies Adjusts Price Target on Teleflex to $230 From $260
A Quick Look at Today's Ratings for Teleflex(TFX.US), With a Forecast Between $245 to $285
Teleflex Analyst Ratings
RBC Cuts Price Target on Teleflex to $245 From $275
Truist Financial Maintains Teleflex(TFX.US) With Hold Rating, Raises Target Price to $255
Teleflex Is Maintained at Outperform by RBC Capital
Teleflex Analyst Ratings
RBC Capital Maintains Teleflex(TFX.US) With Buy Rating, Raises Target Price to $275
BofA Securities Maintains Teleflex(TFX.US) With Hold Rating, Announces Target Price $250
Maintaining Hold on Teleflex Amid Mixed Market Opportunities and Competitive Challenges
Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (ISRG), HCA Healthcare (HCA) and Teleflex (TFX)